CHAPTER 7 REFERENCES

ACOG Committee Opinion Number 642, October 2015: Increasing Access to Contraceptive Implants and Intrauterine Devices to Reduce Unintended Pregnancy. https://bit.ly/2Wc9A65

Ali M, Bahamondes L, Bent Landoulsi S. Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. FDA Product Labeling. Glob Health Sci Pract. 2017 Dec28;5(4):534-539. https://bit.ly/3docVWJ

Amico JR, et al. Taking the provider “out of the loop:” patients’ and physicians’ perspectives about IUD self-removal. Contraception. 2018 Oct;98(4):288-291. https://bit.ly/2KPbft6

ASEC Factsheet:  Providing Ongoing Hormonal Contraception after Use of Emergency Contraceptive Pills, Sep 2016. https://bit.ly/35kYDmS

Bahamondes MV, Espejo-Arce X, Bahamondes L. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT. Hum Reprod. 2015 Aug;30(8):1861-6.  https://bit.ly/2VSBSUd

Bellanca HK, Hunter MS. ONE KEY QUESTION®: Preventive reproductive health is part of high quality primary care. Contraception. 2013 Jul;88(1):3-6. https://bit.ly/2VO7VEO

Becker, Tsui. Reproductive health service preferences and perceptions of quality among low-Income women. Perspectives on Sexual and Reproductive Health, 2008, 40(4) https://bit.ly/2YrDoyt

Birgisson NE et al. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review. J Womens Health (Larchmt). 2015;24(5):349. https://bit.ly/2WcbxPX

Bonnington A, Dianat S, Kerns J, Hawkins M, De Haan G, Obedin-Maliver J. Society of Family Planning clinical recommendations: Contraceptive counseling for transgender and gender diverse people who were assigned female sex at birth. Contraception. April 2020. https://bit.ly/3exiL8I

Boudreau D & Mukerjee R. Contraception Care for Transmasculine individuals on testosterone therapy. Journal of Midwifery & Women’s Health. July/August 2019. 64(4): 395-402. https://bit.ly/2KPpDRS

Brandi K, Woodhams E, White KO, Mehta PK. An exploration of perceived contraceptive coercion at the time of abortion. Contraception. 2018;97(4):329334. https://bit.ly/2X2BXFu

Centers for Disease Control. Providing Quality Family Planning Services: Recommendations of CDC and the U.S. Office of Population Affairs April 25, 2014 / 63(RR04); 1-29. https://bit.ly/2Wb41ox

Centers for Disease Control. United States Selected Practice Recommendations for Contraceptive Use, 2016. MMWR, 2016 https://bit.ly/3bQbxeY

Centers for Disease Control. United States Medical Eligibility Criteria for Contraceptive Use, 2016. MMWR Early Release, 2016 https://bit.ly/2VQC6v7

Cleland K, et al.  The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod. 2012 Jul;27(7):1994-2000.  https://bit.ly/35m19cl

Davies A, Fleming C. Do intrauterine device/intrauterine system users check their threads? J Fam Plann Reprod Health Care. 2014 Apr;40(2):122-5. https://bit.ly/35q9hJ1

Dehlendorf C, et al. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014 Dec;57(4):659-73.  https://bit.ly/3aT0Rer

Dehlendorf C, et al. Association of the quality of interpersonal care during family planning counseling with contraceptive use. Am J Obstet Gynecol. 2016 Jan 28. https://bit.ly/2yVxdI3

Dehlendorf C, et al, D. Development of a patient-reported measure of the interpersonal quality of family planning care. Contraception. 2018 Jan;97(1):34-40. https://bit.ly/2ySK5i9

Diedrich JT, Zhao Q, Madden T, Secura GM, Peipert JF. Three-year continuation of reversible contraception. Am J Obstet Gynecol. 2015 Nov;213(5):662.e1-8. https://bit.ly/3aT2bxV

Edelman A. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Syst Rev. 2014 Jul 29;2014(7):CD004695. https://bit.ly/2Yz9nwB

Foster DG, et al. Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet Gynecol. 2006 Nov;108(5):1107-14.  http://goo.gl/jLmVF

Foster DG, et al. Interest in and experience with IUD self-removal. Contraception. 2014 Jul;90(1):54-9. https://bit.ly/2yTGzUS

Glasier A, et al.  Can we identify women at risk of pregnancy despite using emergency contraception? Contraception 2011; 84:363–367.  https://bit.ly/3fcCwDR

Grossman D.  Routine follow-up visits after first trimester induced abortion.  Obstet Gynecol.  2004 April:  103(4): 738-745.  https://bit.ly/3aT3lcL

Guttmacher Institute. Reasons for Unmet Need for Contraception in Developing Countries. June 2016. https://bit.ly/2VU03lj

Hubacher D, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. New England Journal of Medicine. 2001;345,561-7.   https://bit.ly/2xjN0jo

Krempasky C, Harris M, Abern L, Grimstad F. Contraception across the transmasculine spectrum. American Journal of Obstetrics and Gynecology. 2020 Feb;222(2):134-143. https://bit.ly/2VOcA9E

London A, Jensen JT. Rationale for eliminating the hormone-free interval in modern oral contraceptives. Int J Gynaecol Obstet. 2016 Mar 20. pii: S0020-7292(16)30040-6.  https://bit.ly/3aXXV0d

Lopez LM, et al. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database of Systematic Reviews 2016, Issue 8. Art. No.: CD008452. https://bit.ly/2XXarbA

Matulich M, et al. Understanding women’s desires for contraceptive counseling at the time of first-trimester surgical abortion.Contraception. 2014 Jan;89(1):36-41. https://bit.ly/3aP0a5S

Mody SK, et al. Paracervical Block for Intrauterine Device Placement Among Nulliparous Women: A Randomized Controlled Trial. Obstet Gynecol. 2018;132(3):575582. https://bit.ly/36VGWez

Raifman S, et al. Effect of Knowledge of Self-removability of Intrauterine Contraceptives on Uptake, Continuation, and Satisfaction. Womens Health Issues. 2018 Jan – Feb;28(1):68-74. https://bit.ly/2YhkSZv

Raymond EG, Weaver MA, Louie KS, et al. Effects of Depot Medroxyprogesterone Acetate Injection Timing on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016;128(4):739745. https://bit.ly/308dW1P

Raymond EG, et al. Effect of Immediate Compared With Delayed Insertion of Etonogestrel Implants on Medical Abortion Efficacy and Repeat Pregnancy: A Randomized Controlled Trial. Obstet Gynecol. 2016;127(2):306312. https://bit.ly/3ctKDcu

Shen J, Che Y, Showell E, Chen K, Cheng L. Interventions for emergency contraception.Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD001324. https://bit.ly/3ddSg7w

Sufrin CB, Averbach SH. Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach. Clin Obstet Gynecol. 2014 Dec;57(4):682-93. https://bit.ly/2z1JMkY

Ti AJ, et al. Effectiveness and safety of extending intrauterine device duration: a systematic review. Am J Obstet Gynecol. 2020 Jan 15. https://bit.ly/2W3Wo4h

Turok DK, et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception 2014; 89(3): 222-8. https://bit.ly/2zMqEbl

Winner B, Peipert JF, Zhao Q, Buckel C, Madden T, Allsworth JE, Secura GM. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012 May24;366(21):1998-2007. https://bit.ly/2ySO7ah

Wu S, et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG 2010;117:1205–1210.  https://bit.ly/2SpqBbP

Yee & Simon. Perceptions of Coercion, Discrimination, and other Negative Experiences in Post-Partum Contraceptive Counseling for Low-Income Minority Women. Journal of Health Care for the Poor and Underserved. Volume 22 Number 4. November 2011. https://bit.ly/2KOMtZW

License

EARLY ABORTION TRAINING CURRICULUM Copyright © 2020 by UCSF Bixby Center for Global Reproductive Health. All Rights Reserved.